What Should Happen After Opioid Rehab Ends?
DeBinge opioid transition: When travelling to DeBinge in The Bahamas for OLANI treatment, there is no requirement to complete a separate opioid-free waiting window before arrival. DeBinge uses a medically supervised 4-to-5-day buprenorphine transition. Buprenorphine is introduced to bridge the patient away from full-agonist opioids, stabilised and tapered over the first several days, and the O’Neil Long-Acting Naltrexone Implant is typically inserted around day 4 or 5 while buprenorphine is still being tapered. The planned overlap continues as buprenorphine clears and the implant gradually releases naltrexone. This pathway is clinician-supervised because mistimed naltrexone exposure can precipitate withdrawal.
Based on DeBinge’s clinical experience in The Bahamas since 2018, the implant typically provides its strongest craving and relapse-prevention support on average 9 months, while clinically meaningful opioid-receptor blockade may persist for longer, in some patients up to about 15 months. This longer blockade may continue to reduce opioid effects and overdose risk.
Ongoing recovery: The implant is not a cure. The DeBinge programme includes a full year of professional counselling after implantation to address the behavioural and psychological side of addiction.
Leaving opioid rehab is not the end of recovery. It is a transition from a structured treatment environment into everyday life, where cravings, stress, pain, relationships, work, mental health and access to opioids may again become relevant.
A continuing treatment plan should ideally already be in place before discharge. Depending on individual needs, this may include medication for opioid use disorder, counselling, mental-health care, relapse-prevention planning, naloxone, family or peer support, structured routines and scheduled follow-up with treatment providers.
Rehab should therefore be viewed as one phase of treatment rather than a finish line. The goal after discharge is to carry treatment and recovery support into the environment where the person will actually be living.
Related: For patients considering antagonist-based relapse prevention after rehab, see our guide to how the opioid-to-naltrexone transition works.
Prepared for Medical Review
Dr Fergus Law, BSc, MBChB, FRCPsych
Consultant Psychiatrist specialising in substance misuse and addiction psychiatry.
This article has been prepared as an evidence-informed educational resource and is awaiting formal clinical approval. Until formal review has been completed, it should not be represented as medically reviewed.
View Dr Fergus Law’s professional profile
Rehab Ending Should Be a Transition in Care, Not an Abrupt Stop
Residential rehab can provide structure, separation from substance-use environments, counselling and time to stabilise. The challenge begins when the person leaves that protected setting and returns to ordinary life.
Home may contain responsibilities, family tensions, work stress, pain, financial pressure, loneliness, old friends, previous suppliers and familiar locations associated with opioid use.
The recovery plan therefore needs to work outside the rehabilitation setting.
A more useful question is: “What treatment, medication, support and structure will continue when the person gets home?”
In This Guide
- Planning before discharge
- Medication after rehab
- Continuing counselling
- Mental-health treatment
- Planning for opioid cravings
- Managing relapse triggers
- Returning home
- Family and peer support
- Daily structure
- Naloxone and overdose safety
- The first month after rehab
- If opioid use returns
- Frequently asked questions
- Clinical sources
The Post-Rehab Plan Should Begin Before Discharge
Discharge planning is stronger when the person does not have to build an entire recovery system after arriving home.
Important arrangements can be made while the person is still in treatment.
Next Clinical Appointment
A follow-up appointment should ideally already have a date, provider and clear method of contact.
Medication Plan
If medication for opioid use disorder is being used, there should be a plan for continuing it without unnecessary interruption.
Counselling
Therapy or counselling should have a clear continuation pathway rather than ending automatically with residential treatment.
Overdose Prevention
Naloxone access and an overdose-response plan should be considered wherever future opioid exposure remains possible.
Housing and Triggers
The person should know where they are returning and whether that environment contains major relapse risks.
Return-to-Use Plan
Everyone involved should know who to contact if cravings intensify or opioid use occurs again.
The practical question is whether the person can move directly from residential treatment into the next layer of care.
Medication Should Not Automatically End When Rehab Ends
People with opioid use disorder may benefit from continuing evidence-based medication treatment after residential rehab.
FDA-approved medications for opioid use disorder include buprenorphine, methadone and naltrexone.
Buprenorphine
Buprenorphine can suppress withdrawal symptoms, reduce opioid cravings and form part of continuing OUD treatment.
Methadone
Methadone can reduce opioid withdrawal and cravings and may be continued as longer-term treatment.
Naltrexone
Naltrexone blocks opioid receptors and requires appropriate opioid-free preparation before treatment begins.
Decisions about continuing, changing or discontinuing medication should be made with the treating clinician according to individual circumstances.
CDC recommends offering or arranging evidence-based medication treatment for people with opioid use disorder.
Learn more in the DeBinge guide to preventing opioid relapse after detox or rehab .
Where Can Naltrexone Fit After Rehab?
Naltrexone is an opioid receptor antagonist. Unlike methadone and buprenorphine, it does not activate opioid receptors.
When adequate levels are present, naltrexone can block or substantially reduce opioid effects.
For appropriately selected patients who have completed the necessary opioid-free period, naltrexone may form part of a continuing relapse-prevention plan.
Counselling, mental-health care, trigger management, environmental planning and continuing clinical support may still be required.
Long-Acting Naltrexone
Longer-acting formulations may reduce reliance on repeated daily medication decisions, which can be relevant where adherence is an important treatment concern.
Naltrexone implant formulations are not FDA-approved for routine clinical use in the United States. DeBinge treatment involving long-acting implant-based naltrexone takes place in Nassau, The Bahamas following individual assessment.
Learn more: Long-Acting Naltrexone Implant .
Continuing Counselling Can Help Transfer Recovery Into Everyday Life
Residential rehab can create an environment where counselling is built into the daily schedule.
After discharge, that structure disappears unless continuing appointments are deliberately arranged.
Craving Management
Counselling can help identify when cravings occur and strengthen responses before opioid use happens.
Relapse Triggers
Real-life experiences after discharge may reveal triggers that were not visible inside residential treatment.
Relationships
Family conflict, boundaries, trust and previous substance-using relationships may require continuing work.
Recovery Decisions
Counselling provides a place to review warning signs before small changes become larger problems.
SAMHSA’s TIP 63 notes that people receiving medication for OUD can benefit from individualized psychosocial and recovery supports according to their needs.
Mental-Health Treatment May Need to Continue After Rehab
Depression, anxiety, trauma-related symptoms, insomnia and other mental-health concerns do not necessarily disappear because residential addiction treatment has ended.
For some people, these problems were closely connected with opioid use before treatment.
If untreated anxiety, depression, trauma, sleep problems or another psychiatric condition remains active, appropriate mental-health follow-up can be an important part of relapse prevention.
Treatment should be individualised rather than assuming that every person leaving rehab needs the same psychological intervention.
There Should Be a Clear Plan for Opioid Cravings
A person can leave rehab motivated and still experience a strong opioid craving later.
A craving may be activated by a person, place, emotion, physical pain, conflict, boredom or sudden opportunity to obtain opioids.
The person should therefore know what to do before that moment arrives.
- Who should be contacted when cravings become strong?
- Which environments should be left immediately?
- Which previous contacts should remain blocked?
- What should happen if medication is missed?
- When should the treatment provider be contacted?
- Where can the person go if being alone becomes unsafe?
Relapse Triggers Need to Be Managed in the Environment Where Recovery Happens
Residential rehab can temporarily separate the person from many triggers.
After discharge, those triggers may return quickly.
Previous Contacts
People associated with obtaining or using opioids may attempt to reconnect.
Familiar Places
Streets, homes, hotels or neighbourhoods can activate memories and cravings.
Money
Payday or sudden access to cash may have been connected with previous opioid use.
Stress
Work, bills, family responsibilities and relationship conflict return after rehab.
Pain
Physical pain may reactivate thoughts about opioids and requires an appropriate treatment plan.
Isolation
Long periods alone may make repetitive opioid thoughts and cravings more difficult to interrupt.
A relapse-prevention strategy should therefore identify the person’s opioid relapse risks before problems escalate .
The Home Environment Should Support Recovery
Returning to exactly the same environment that existed before rehab can create a difficult transition.
The person may have changed significantly during treatment while the environment around them has changed very little.
Questions worth discussing include:
- Is the home stable and safe?
- Are opioids or other substances present in the home?
- Can previous suppliers still contact the person easily?
- Does someone living there actively use substances?
- Will the person spend long periods alone?
- How will transport to treatment appointments work?
- What happens during previously high-risk times of day?
- Is there a plan for conflict or overwhelming stress?
DeBinge also has a dedicated guide to continuing recovery after returning home from addiction treatment .
Family and Peer Support Can Help Maintain Recovery
Recovery after rehab often involves other people, but support should not become constant surveillance or conflict.
Family members and trusted supporters can be most useful when their role is clear.
Know the Warning Signs
Understand which changes in behaviour, treatment attendance or social contact may indicate increasing risk.
Know the Plan
Know whom to contact if cravings intensify or opioid use returns.
Learn Naloxone Use
Household members can learn how to recognise a suspected opioid overdose and administer naloxone.
Support Treatment
Practical help with appointments, transport, routines and recovery activities can be useful.
Daily Routine Matters After Residential Treatment
Residential treatment usually provides a schedule automatically.
After discharge, the person may suddenly have large amounts of unstructured time.
A practical routine can help reduce periods in which boredom, isolation or stress begin driving opioid thoughts.
| Area | Question to Answer |
|---|---|
| Sleep | What time will the person sleep and wake each day? |
| Treatment | When are medication, counselling and clinical appointments? |
| Work or Education | How quickly should responsibilities resume? |
| Physical Activity | What regular activity can become part of the week? |
| Social Contact | Who are the safe people the person will spend time with? |
| High-Risk Periods | What will replace the time when opioid use previously occurred? |
| Downtime | How will boredom and long periods alone be managed? |
Structure should support recovery without turning life into an unrealistic timetable that cannot be maintained.
Naloxone Should Remain Part of the Post-Rehab Safety Plan
A period without opioid use can reduce opioid tolerance.
If a person later returns to an amount they previously used, the risk of severe respiratory depression and overdose may be greater than expected.
CDC recommends offering naloxone and education on its use to patients with opioid use disorder and to household members or significant others.
It is an emergency safety measure for a potentially life-threatening event.
If someone is unresponsive, cannot be awakened or has very slow or stopped breathing after possible opioid exposure, give naloxone if available and contact emergency services immediately.
What Should the First Month After Rehab Look Like?
There is no universal schedule that is correct for every person. The following framework illustrates the kinds of issues that may need attention during the transition home.
Connect the Next Stage
Confirm medication, clinical appointments, counselling, housing, transport, naloxone and the craving-response plan.
Protect the Transition
Reduce unnecessary exposure to previous opioid environments and make sure planned treatment actually begins.
Watch Real-Life Patterns
Review cravings, sleep, mood, appointments, medication adherence, family relationships and emerging triggers.
Review What Is Working
Treatment may need adjustment according to what has happened since the person returned to everyday life.
Keep Treatment Active
Continue the medication, counselling, mental-health and recovery supports that remain clinically appropriate.
Respond Early
Do not wait for opioid use to occur before increasing treatment support when warning signs are appearing.
The early transition can be particularly important. Read: When Is Opioid Relapse Risk Highest After Detox?
Warning Signs That the Post-Rehab Plan May Need More Support
- counselling appointments are repeatedly missed;
- medication is being skipped or stopped without medical guidance;
- opioid cravings are becoming stronger;
- the person becomes increasingly isolated;
- sleep becomes significantly disrupted;
- depression, anxiety or other mental-health symptoms worsen;
- previous opioid-using contacts reappear;
- high-risk locations are being revisited;
- alcohol or other substance use increases;
- the person begins contacting previous suppliers;
- opioids are being actively searched for or obtained.
These signs do not prove that opioid use will occur, but they are reasons to reassess the current plan rather than waiting for a more serious event.
A Return to Use Should Lead to Rapid Reassessment, Not the End of Treatment
If opioids are used again after rehab, immediate safety comes first.
Reduced tolerance may make the amount used before treatment more dangerous after a period of abstinence.
Give naloxone if available, contact emergency services immediately and remain with the person until professional help arrives.
After immediate safety has been addressed, treatment should be re-engaged quickly.
The episode can be examined to understand whether medication, cravings, mental health, environmental exposure, treatment attendance or another part of the recovery plan needs to change.
Leaving Rehab Is When Relapse Prevention Moves Into Everyday Life
Medication, cravings, triggers, counselling, mental health, family support, the home environment, naloxone and early intervention all form part of the wider opioid relapse-prevention plan.
Discuss a Continuing Recovery Plan
DeBinge provides addiction treatment in Nassau, The Bahamas. For suitable patients, assessment may include discussion of long-acting naltrexone alongside counselling and continuing recovery planning.
Treatment suitability depends on individual factors including current opioid exposure, previous treatment, medication history, detox status, physical health, mental health and recovery goals.
What Happens After Opioid Rehab? FAQs
What should happen immediately after opioid rehab ends?
Continuing care should ideally already be arranged before discharge. This may include medication for opioid use disorder, counselling, mental-health care, naloxone, recovery support and a practical relapse-prevention plan.
Does opioid treatment end when rehab ends?
It should not automatically end. Opioid use disorder may require continuing treatment after residential care, including medication and other supports according to the person’s needs.
Should medication continue after rehab?
Medication should not be stopped simply because residential treatment has ended. Decisions about buprenorphine, methadone, naltrexone or another prescribed treatment should be made with the treating clinician.
What medications are approved for opioid use disorder?
FDA-approved medications for opioid use disorder include buprenorphine, methadone and naltrexone.
Should counselling continue after rehab?
Counselling may be useful after rehab for addressing cravings, relapse triggers, coping, relationships and other individual recovery needs. The appropriate type and frequency depend on the person.
Why can someone relapse after completing rehab?
Rehab may provide temporary separation from opioid-related triggers, but cravings, stress, mental-health symptoms, pain, social contacts and environmental risks can return after discharge.
Should someone carry naloxone after rehab?
Where opioid exposure remains possible, naloxone and overdose-response education should remain part of the safety plan.
How important is the first month after opioid rehab?
The early transition home can be particularly important because treatment routines, medication, relationships and environmental triggers are being tested outside the residential setting. Risk does not disappear after the first month, so continuing care should extend beyond it.
What should family members do after someone returns from rehab?
Family members can support treatment attendance, understand warning signs, learn overdose response, maintain reasonable boundaries and know whom to contact if relapse risk increases.
What should happen if opioids are used again after rehab?
Immediate overdose safety comes first. If overdose is suspected, give naloxone if available and contact emergency services. Afterward, reconnect with treatment promptly and reassess the current recovery plan.
Are naltrexone implants FDA-approved in the United States?
No. Naltrexone implant formulations are not FDA-approved for routine clinical use in the United States.
Evidence Used in This Guide
CDC — Opioid Use Disorder: Treating
CDC guidance covering medications for opioid use disorder, psychosocial treatment considerations and naloxone education.
FDA — Medications for Opioid Use Disorder
Current FDA information on buprenorphine, methadone and naltrexone as approved medications for opioid use disorder.
SAMHSA — TIP 63: Medications for Opioid Use Disorder
SAMHSA’s Treatment Improvement Protocol reviews buprenorphine, methadone and naltrexone together with recovery, mental-health and psychosocial services that may support people with opioid use disorder.
SAMHSA — Recovery and Recovery Support
SAMHSA describes recovery as an ongoing process involving health, wellness, self-directed living and reaching individual potential.
Clinical recommendations, approved products and regulatory information can change. Individual treatment decisions should be made with appropriately qualified healthcare professionals.
Related: For patients considering antagonist-based relapse prevention after rehab, see our guide to how the opioid-to-naltrexone transition works.
Prepared for Medical Review
Dr Fergus Law, BSc, MBChB, FRCPsych
Consultant Psychiatrist specialising in substance misuse and addiction psychiatry.
This article has been prepared as an educational resource concerning continuing opioid-use-disorder treatment, relapse prevention and recovery after residential rehabilitation. It is awaiting formal clinical approval.
View Dr Fergus Law’s professional profile
This Article Does Not Replace Individual Medical Care
This page provides general educational information. It does not diagnose opioid use disorder, determine treatment suitability or recommend a specific medication, level of care or recovery plan for an individual.
Do not abruptly stop methadone, buprenorphine, prescribed opioids or another prescribed medication based on this article. Medication changes should be discussed with an appropriately qualified clinician.
Naltrexone requires appropriate opioid-free preparation before initiation. Starting naltrexone while significant opioid physical dependence remains can precipitate withdrawal.
If someone is unconscious, cannot be awakened, has very slow or stopped breathing, or opioid overdose is suspected, administer naloxone if available and contact local emergency services immediately.
DeBinge is located in Nassau, The Bahamas. We do not operate a treatment facility in the United States. Naltrexone implant formulations are not FDA-approved for routine clinical use in the United States.